Skip to main content

Vermillion Distributes Shares to Board, CSO

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Vermillion said last week that it has distributed shares to certain board members and its chief scientific officer pursuant to its debtor incentive plan.

Board members James Burns and John Hamilton each received 35,295 shares of the company's stock pursuant to the incentive plan, which was approved by the US Bankruptcy Court in Delaware in April as part of the company's plan to emerge from Chapter 11 protection. Vermillion emerged from Chapter 11 protection earlier this year.

Burns and Hamilton were each granted 60,508 shares of common stock under the incentive plan, subject to a 24-month vesting schedule that began on June 22, 2009.The remaining 25,213 shares granted to Burns and Hamilton each will vest monthly over the next 10 months, the company said.

Also Vermillion, now based in Austin, Texas, said that its board has approved the granting of 20,169 restricted shares of its common stock to CSO Eric Fung. The shares are subject to a 24-month vesting schedule that began on June 22, 2009, and 11,765 of those shares are vested and have been distributed to Fung. The remaining 8,404 shares will vest over the next 10 months.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.